Ochratoxin A induces rat renal carcinogenicity with limited induction of oxidative stress responses

Toxicology and Applied Pharmacology

Volumn 280, Issue 3, 2014, Pages 543-549

  Qi, Xiaozhe ^a   Yu, Tao ^a   Zhu, Liye ^a   Gao, Jing ^a   He, Xiaoyun ^a,b   Huang, Kunlun ^a,b   Luo, Yunbo ^a,b   Xu, Wentao ^a,b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

Author keywords

Cell proliferation; Nephrotoxicity; Ochratoxin A; Oxidative stress; Renal carcinogenicity

Indexed keywords

CLUSTERIN; CYCLINE; KIDNEY INJURY MOLECULE 1; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OCHRATOXIN; REACTIVE OXYGEN METABOLITE; VIMENTIN; CELL ADHESION MOLECULE; GLUTATHIONE; HAVCR1PROTEIN, RAT; MALONALDEHYDE; RNA; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; KIDNEY CANCER; KIDNEY INJURY; KIDNEY TUBULE CELL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; UPREGULATION; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; COMET ASSAY; DRUG EFFECTS; FISCHER 344 RAT; GENETICS; KIDNEY TUMOR; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TOXICITY;

ANIMALS; CELL ADHESION MOLECULES; CELL PROLIFERATION; CLUSTERIN; COMET ASSAY; GLUTATHIONE; KIDNEY NEOPLASMS; MALE; MALONDIALDEHYDE; OCHRATOXINS; OXIDATIVE STRESS; RATS, INBRED F344; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SUPEROXIDE DISMUTASE;

EID: 84908374933     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.08.030     Document Type: Article

References (52)

1. Amson R., Pece S., Lespagnol A., Vyas R., Mazzarol G., Tosoni D., Colaluca I., Viale G., Rodrigues-Ferreira S., Wynendaele J. Reciprocal repression between P53 and TCTP. Nat. Med. 2012, 18:91-99.
2. Anyukhovsky E.P., Sosunov E.A., Rosen M.R. Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium. In vitro and in vivo correlations. Circulation 1996, 94:1981-1988.
3. Apel K., Hirt H. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu. Rev. Plant Biol. 2004, 55:373-399.
4. Boesch-Saadatmandi C., Loboda A., Jozkowicz A., Huebbe P., Blank R., Wolffram S., Dulak J., Rimbach G. Effect of ochratoxin A on redox-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells. Food Chem. Toxicol. 2008, 46:2665-2671.
5. Bonventre J.V. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand. J. Clin. Lab. Invest. Suppl. 2008, 241:78-83.
6. Cavin C., Delatour T., Marin-Kuan M., Holzhäuser D., Higgins L., Bezencon C., Guignard G., Junod S., Richoz-Payot J., Gremaud E. Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol. Sci. 2007, 96:30-39.
7. Czakai K., Müller K., Mosesso P., Pepe G., Schulze M., Gohla A., Patnaik D., Dekant W., Higgins J.M., Mally A. Perturbation of mitosis through inhibition of histone acetyltransferases: the key to ochratoxin A toxicity and carcinogenicity?. Toxicol. Sci. 2011, 122:317-329.
8. Dai Q., Zhao J., Qi X., Xu W., He X., Guo M., Dweep H., Cheng W.-H., Luo Y., Xia K., Gretz N., Huang K. MicroRNA profiling of rats with ochratoxin A nephrotoxicity. BMC Genomics 2014, 15:333.
9. Di Giacomo C., Acquaviva R., Piva A., Sorrenti V., Vanella L., Piva G., Casadei G., La Fauci L., Ritieni A., Bognanno M., Di Renzo L., Barcellona M.L., Morlacchini M., Galvano F. Protective effect of cyanidin 3-O-beta-d-glucoside on ochratoxin A-mediated damage in the rat. Br. J. Nutr. 2007, 98:937-943.
10. Domijan A.M., Peraica M., Vrdoljak A.L., Radic B., Zlender V., Fuchs R. The involvement of oxidative stress in ochratoxin A and fumonisin B1 toxicity in rats. Mol. Nutr. Food Res. 2007, 51:1147-1151.
11. Dvergsten J., Manivel J.C., Correa-Rotter R., Rosenberg M.E. Expression of clusterin in human renal diseases. Kidney Int. 1994, 45:828-835.
12. Gautier J.C., Holzhaeuser D., Markovic J., Gremaud E., Schilter B., Turesky R.J. Oxidative damage and stress response from ochratoxin A exposure in rats. Free Radic. Biol. Med. 2001, 30:1089-1098.
13. Guo M., Huang K., Chen S., Qi X., He X., Cheng W.H., Luo Y., Xia K., Xu W. Combination of metagenomics and culture-based methods to study the interaction between ochratoxin A and gut microbiota. Toxicol. Sci. 2014, 141:314-323.
14. Hibi D., Suzuki Y., Ishii Y., Jin M., Watanabe M., Sugita-Konishi Y., Yanai T., Nohmi T., Nishikawa A., Umemura T. Site-specific in vivo mutagenicity in the kidney of gpt delta rats given a carcinogenic dose of ochratoxin A. Toxicol. Sci. 2011, 122:406-414.
15. Hibi D., Kijima A., Kuroda K., Suzuki Y., Ishii Y., Jin M., Nakajima M., Sugita-Konishi Y., Yanai T., Nohmi T., Nishikawa A., Umemura T. Molecular mechanisms underlying ochratoxin A-induced genotoxicity: global gene expression analysis suggests induction of DNA double-strand breaks and cell cycle progression. J. Toxicol. Sci. 2013, 38:57-69.
16. Hoehler D., Marquardt R.R., Rohlich A.A. Lipid peroxidation as one mode of action in ochratoxin A toxicity in rats and chicks. Can. J. Anim. Sci. 1997, 77:287-292.
17. Jackson P., Pedersen L.M., Kyjovska Z.O., Jacobsen N.R., Saber A.T., Hougaard K.S., Vogel U., Wallin H. Validation of freezing tissues and cells for analysis of DNA strand break levels by comet assay. Mutagenesis 2013, 28:699-707.
18. Kamp H.G., Eisenbrand G., Janzowski C., Kiossev J., Latendresse J.R., Schlatter J., Turesky R.J. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol. Nutr. Food Res. 2005, 49:1160-1167.
19. Kamp H.G., Eisenbrand G., Schlatter J., Wurth K., Janzowski C. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 2005, 206:413-425.
20. Kumar R., Ansari K.M., Chaudhari B.P., Dhawan A., Dwivedi P.D., Jain S.K., Das M. Topical application of ochratoxin A causes DNA damage and tumor initiation in mouse skin. PLoS One 2012, 7:e47280.
21. Lebrun S., Follmann W. Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay). Arch. Toxicol. 2002, 75:734-741.
22. Liu J., Wang Y., Cui J., Xing L., Shen H., Wu S., Lian H., Wang J., Yan X., Zhang X. Ochratoxin A induces oxidative DNA damage and G1 phase arrest in human peripheral blood mononuclear cells in vitro. Toxicol. Lett. 2012, 211:164-171.
23. T method. Methods 2001, 25:402-408.
24. Maier H.T., Aigner F., Trenkwalder B., Zitt M., Vallant N., Perathoner A., Margreiter C., Moser P., Pratschke J., Amberger A. Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival. World J. Surg. 2014, 38:2160-2167.
25. Mally A., Dekant W. Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents. Mol. Nutr. Food Res. 2009, 53:467-478.
26. McBride O.W., Merry D., Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc. Natl. Acad. Sci. U. S. A. 1986, 83:130-134.
27. Meki A.R., Hussein A.A. Melatonin reduces oxidative stress induced by ochratoxin A in rat liver and kidney. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2001, 130:305-313.
28. Motoyoshi Y., Kaminoda K., Saitoh O., Hamasaki K., Nakao K., Ishii N., Nagayama Y., Eguchi K. Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide. Oncol. Rep. 2006, 16:141-146.
29. Nakae D., Mizumoto Y., Kobayashi E., Noguchi O., Konishi Y. Improved genomic/nuclear DNA extraction for 8-hydroxydeoxyguanosine analysis of small amounts of rat liver tissue. Cancer Lett. 1995, 97:233-239.
30. Nakae D., Kobayashi Y., Akai H., Andoh N., Satoh H., Ohashi K., Tsutsumi M., Konishi Y. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res. 1997, 57:1281-1287.
31. O'Brien E., Dietrich D.R. Ochratoxin A: the continuing enigma. Crit. Rev. Toxicol. 2005, 35:33-60.
32. Petrik J., Zanic-Grubisic T., Barisic K., Pepeljnjak S., Radic B., Ferencic Z., Cepelak I. Apoptosis and oxidative stress induced by ochratoxin A in rat kidney. Arch. Toxicol. 2003, 77:685-693.
33. Pfohl-Leszkowicz A., Manderville R.A. An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity. Chem. Res. Toxicol. 2012, 25:252-262.
34. Pomar F.J., Teerds K.J., Kidson A., Colenbrander B., Tharasanit T., Aguilar B., Roelen B.A. Differences in the incidence of apoptosis between in vivo and in vitro produced blastocysts of farm animal species: a comparative study. Theriogenology 2005, 63:2254-2268.
35. Qi X., Yang X., Chen S., He X., Dweep H., Guo M., Cheng W.-H., Xu W., Luo Y., Gretz N. Ochratoxin A induced early hepatotoxicity: new mechanistic insights from microRNA, mRNA and proteomic profiling studies. Sci. Rep. 2014, (Article number: 5163). 10.1038/srep05163.
36. Sayin V.I., Ibrahim M.X., Larsson E., Nilsson J.A., Lindahl P., Bergo M.O. Antioxidants accelerate lung cancer progression in mice. Sci. Transl. Med. 2014, 6:221ra215.
37. Schaaf G.J., Nijmeijer S.M., Maas R.F., Roestenberg P., de Groene E.M., Fink-Gremmels J. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim. Biophys. Acta 2002, 1588:149-158.
38. Shen X.L., Zhang Y., Xu W., Liang R., Zheng J., Luo Y., Wang Y., Huang K. An iTRAQ-based mitoproteomics approach for profiling the nephrotoxicity mechanisms of ochratoxin A in HEK 293 cells. J. Proteomics 2013, 78:398-415.
39. Simms D., Cizdziel P.E., Chomczynski P. TRIzol: a new reagent for optimal single-step isolation of RNA. Focus 1993, 15:532-535.
40. Soyoz M., Ozcelik N., Kilinc I., Altuntas I. The effects of ochratoxin A on lipid peroxidation and antioxidant enzymes: a protective role of melatonin. Cell Biol. Toxicol. 2004, 20:213-219.
41. Taniai E., Yafune A., Nakajima M., Hayashi S.M., Nakane F., Itahashi M., Shibutani M. Ochratoxin A induces karyomegaly and cell cycle aberrations in renal tubular cells without relation to induction of oxidative stress responses in rats. Toxicol. Lett. 2014, 224:64-72.
42. Traverso N., Ricciarelli R., Nitti M., Marengo B., Furfaro A.L., Pronzato M.A., Marinari U.M., Domenicotti C. Role of glutathione in cancer progression and chemoresistance. Oxidative Med. Cell. Longev. 2013, 2013:972913.
43. Utgikar V.P., Chaudhary N., Koeniger A., Tabak H.H., Haines J.R., Govind R. Toxicity of metals and metal mixtures: analysis of concentration and time dependence for zinc and copper. Water Res. 2004, 38:3651-3658.
44. Van den Belt K., Berckmans P., Vangenechten C., Verheyen R., Witters H. Comparative study on the in vitro/in vivo estrogenic potencies of 17beta-estradiol, estrone, 17alpha-ethynylestradiol and nonylphenol. Aquat. Toxicol. 2004, 66:183-195.
45. Verma R., Chakraborty D. Emblica officinalis aqueous extract ameliorates ochratoxin-induced lipid peroxidation in the testis of mice. Acta Pol. Pharm. 2008, 65:187-194.
46. Viau A., El Karoui K., Laouari D., Burtin M., Nguyen C., Mori K., Pillebout E., Berger T., Mak T.W., Knebelmann B. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J. Clin. Invest. 2010, 120:4065-4076.
47. Vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., Dhar M.D., Ganjam V., Parmigiani S., Welshons W.V. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc. Natl. Acad. Sci. 1997, 94:2056-2061.
48. Wojcik M., Ramadori P., Blaschke M., Sultan S., Khan S., Malik I.A., Naz N., Martius G., Ramadori G., Schultze F.C. Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma. Histochem. Cell Biol. 2012, 137:217-233.
49. Xu J.H., Zhang C., Tang B., Hao Y.X., Chen J., Liu T., Cui H. Effect of JAK2/STAT3/vimentin signaling pathway on proliferation and migration of human colon cancer cells. Zhonghua Wei Chang Wai Ke Za Zhi 2010, 13:282-285.
50. Yamasaki T., Seki N., Yamada Y., Yoshino H., Hidaka H., Chiyomaru T., Nohata N., Kinoshita T., Nakagawa M., Enokida H. Tumor suppressive microRNA-138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Int. J. Oncol. 2012, 41:805-817.
51. Zheng L.T., Lee S., Yin G.N., Mori K., Suk K. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells. J. Neurochem. 2009, 111:1238-1251.
52. Zheng J., Zhang Y., Xu W., Luo Y., Hao J., Shen X.L., Yang X., Li X., Huang K. Zinc protects HepG2 cells against the oxidative damage and DNA damage induced by ochratoxin A. Toxicol. Appl. Pharmacol. 2013, 268:123-131.